Skip to content

Understanding Your Medical Test: A Patient's Guide to Laboratory Testing

Published: August 9, 2026Updated: August 16, 2026

Acarboxyprothrombin (DCP) is a blood test that measures an abnormal form of protein produced primarily by liver cancer cells.

Quick summary

{"DCP is a tumor marker mainly used to detect and monitor hepatocellular carcinoma (liver cancer)","The test is performed on a blood sample (serum or plasma)","Elevated DCP levels suggest liver cancer, but further testing is needed for confirmation","DCP is often used together with AFP (alpha-fetoprotein) for better accuracy","This test helps doctors assess treatment response and check for cancer recurrence"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
93768-0
Short code
DCP|PIVKA-II
Synonyms
Acarboxyprothrombin SerPl-aCnc
Category
chemistry
Sample
serum
Container
Serum separator tube (SST) or plain red top tube
Units
N/A
Ref low
0
Ref high
20
Fasting
false
Population
adult
Sex
all
Age range
≥ 18 years
Method
Chemiluminescence Immunoassay (CLIA) or Enzyme Immunoassay (EIA)
CPT
86255
SNOMED
118619007
Specimen volume
1-2 mL serum
Stability
Room temperature: 24 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C): 30 days
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
24–72 hours
Order
routine

This test is a laboratory procedure that helps your health care provider evaluate your health by analyzing a sample, such as blood, urine, or tissue, in order to detect, diagnose, or monitor a medical condition.

The acarboxyprothrombin (DCP) test measures the amount of an abnormal protein in your blood. This protein, also called des-gamma-carboxyprothrombin (DCP), is produced by liver cells when they become cancerous. Normally, liver cells produce a protein called prothrombin (Factor II), which helps blood clot. In liver cancer cells, this protein is produced in an abnormal form that cannot function properly for blood clotting.

Your doctor may order this test to help diagnose the cause of your symptoms, check how well an organ is working, screen for disease before symptoms appear, or monitor how well a treatment you are already receiving is working.

Your doctor may order this test if they suspect you have liver cancer (hepatocellular carcinoma or HCC), especially if you have risk factors such as chronic hepatitis B or C, cirrhosis, or a family history of liver cancer. The test helps in diagnosing liver cancer, monitoring treatment effectiveness, and checking if cancer has returned after treatment. DCP is often ordered together with AFP (alpha-fetoprotein) because using both markers improves detection rates.

The test is usually performed by a trained health care professional in a clinic, hospital, or laboratory. A small sample is collected and then sent for analysis. The procedure is typically quick, and most people experience only minimal discomfort.

A healthcare professional will draw a small blood sample from a vein in your arm. The blood is collected into a tube and sent to a laboratory for analysis. You do not need to fast before this test. The results are typically available within a few days.

Your results show whether your values fall within the normal reference range for this test. Normal results generally suggest no abnormality, while results outside the range may point to a condition that needs further evaluation. Your doctor will interpret the findings together with your symptoms and medical history.

Results are reported as units per milliliter (U/mL) or ng/mL. Normal results vary by laboratory, but generally, higher levels of DCP are associated with a higher likelihood of hepatocellular carcinoma. However, elevated DCP does not automatically mean you have cancer—other liver conditions can sometimes cause mild elevations. Your doctor will interpret your results alongside other tests, imaging studies (like ultrasound or CT scan), and your overall clinical situation.

Most laboratory tests carry very few risks. You may feel a brief sting when the needle is inserted, and slight soreness or minor bruising at the site is common. Serious complications such as infection or excessive bleeding are rare. Contact your doctor if you notice unusual swelling, ongoing bleeding, or fever.

The risks associated with this blood test are minimal and include slight bruising, bleeding, or infection at the puncture site. These complications are rare and usually resolve quickly.

Reference range

<20 ng/mL (varies by laboratory and methodology)N/A

Specimen: serum

No special preparation required. This test does not require fasting.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Acarboxyprothrombin (DCP) serves as a valuable tumor marker for hepatocellular carcinoma (HCC), the most common type of primary liver cancer. Elevated DCP levels are found in approximately 60-70% of HCC patients. The test is particularly useful for monitoring patients at high risk for liver cancer, such as those with chronic hepatitis B or C, alcoholic liver disease, or cirrhosis. When combined with AFP testing, the sensitivity for detecting HCC increases significantly. DCP levels can also help assess the stage of cancer and predict prognosis—higher levels often indicate more advanced disease. During treatment (such as surgery, ablation, or targeted therapy), declining DCP levels may suggest effective treatment, while rising levels may indicate disease progression or recurrence.

Frequently asked questions

Do I need to fast before the DCP test?
No, you do not need to fast before this test. You can eat and drink normally before having your blood drawn. However, always follow any specific instructions your doctor gives you.
Can DCP levels be elevated for reasons other than cancer?
Yes, in rare cases, other conditions may cause mild to moderate elevation of DCP, including vitamin K deficiency, certain liver diseases (like chronic hepatitis or cirrhosis), and the use of blood-thinning medications like warfarin. However, levels in these conditions are usually much lower than those seen in liver cancer.
How often should DCP be monitored?
The frequency of monitoring depends on your specific situation. For patients at high risk for HCC, doctors may check DCP (along with AFP) every 6-12 months as part of surveillance. If you have been treated for HCC, your doctor may order the test more frequently (every 1-3 months) to monitor for recurrence. Follow your doctor's recommendations for testing schedule.
Is the DCP test painful?
You may feel a brief pinch or sting when the needle is inserted to draw blood. This is generally well-tolerated. The discomfort is temporary and lasts only a few seconds.
What happens if my DCP level is elevated?
If your DCP level is elevated, your doctor will likely order additional tests to determine the cause. These may include imaging studies (ultrasound, CT scan, or MRI) to look for tumors in the liver, and possibly a biopsy if a suspicious mass is found. Your doctor will interpret the results in the context of your medical history and other test findings.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy